4.1. Drivers
4.1.1. Growing potential of spatial OMICS as a cancer diagnostic tool
4.1.2. Increasing adoption of spatial OMICS in drug discovery and development
4.2. Restraints
4.2.1. Lack of skilled professionals
4.3. Opportunities
4.3.1. Growing usage of spatial OMICS for biomarker identification
4.4. Impact of COVID-19 on Spatial OMICS Market
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition